|
Individual and mean pharmacokinetic parameters of ceftazidime |
|||||
| Pharmacokinetic parameters |
Css |
AUC0–72 |
CLtot |
Vd |
T1/2 |
|
|
|||||
| Patient 1 |
35.2 |
2625.0 |
59.2 |
19.0 |
3.7 |
| Patient 2 |
34.3 |
2655.0 |
60.8 |
12.4 |
2.8 |
| Patient 3 |
28.8 |
2146.0 |
72.3 |
17.7 |
2.8 |
| Patient 4 |
32.5 |
2372.0 |
64.1 |
29.4 |
5.3 |
| Patient 5 |
36.3 |
2795.0 |
57.5 |
24.1 |
5.0 |
| Patient 6 |
33.6 |
2471.0 |
62.0 |
13.7 |
2.6 |
| Patient 7 |
34.2 |
2536.0 |
61.0 |
15.8 |
3.0 |
| Mean |
33.5 |
2514.3 |
62.4 |
18.9 |
3.6 |
| Standard deviation |
2.4 |
211.8 |
4.8 |
6.0 |
1.1 |
|
AUC0–72 h, area under the concentration time-curve from time zero to 72 hours (mg/hour per l); CLtot, total clearance of ceftazidime (ml/min); Css, steady-state serum ceftazidime concentration (mg/l); T1/2, elimination half-life (hours); Vd, volume of distribution (l). | |||||
Mariat et al. Critical Care 2006 10:R26 doi:10.1186/cc3993 |
|||||